Vernon K. Sondak

Also affiliated with Advanced Dermatology

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 6%percentile

0.261Author DataRank

Indexed papers

3in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Natural History of Incident and Persistent Cutaneous Human Papillomavirus and Human Polyomavirus Infections

The Journal of Infectious Diseases(2022)10.1093/infdis/jiac004

Top 59%

0.261DataRank

Top 59%4 citations

Yayi Zhao, Neil A. Fenske, Basil S. Cherpelis, Jane L. Messina, Anna R. Giuliano +8 more

Papers

Driven by 42 papers — median percentile 0. Top paper: “Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma”.

Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma

New England Journal of Medicine(2023)10.1056/nejmoa2211437

N/A

6.5DataRank · unranked

846 citations

Megan Othus, Yuanbin Chen, G. Paul Wright, Kathleen J. Yost, John Hyngstrom +48 more

Final analysis of overall survival (OS) and relapse-free-survival (RFS) in the intergroup S1404 phase III randomized trial comparing either high-dose interferon (HDI) or ipilimumab to pembrolizumab in patients with high-risk resected melanoma.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.9501

N/A

1.3DataRank · unranked

18 citations

Megan Othus, Sapna P. Patel, Ahmad A. Tarhini, Vernon K. Sondak, Teresa M. Petrella +15 more

The State of Melanoma: Emergent Challenges and Opportunities

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4092

N/A

0.705DataRank · unranked

109 citations

Clara Curiel‐Lewandrowski, David E. Fisher, Susan M. Swetter, Hensin Tsao, Julio A. Aguirre‐Ghiso +31 more

Enhanced immune activation within the tumor microenvironment and circulation of female high-risk melanoma patients and improved survival with adjuvant CTLA4 blockade compared to males

Journal of Translational Medicine(2022)10.1186/s12967-022-03450-3

N/A

0.614DataRank · unranked

12 citations

Sandra J. Lee, Aik Choon Tan, Issam M. El Naqa, F. Stephen Hodi, Lisa H. Butterfield +10 more

Combination Nivolumab, CD137 Agonism, and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-2103

N/A

0.571DataRank · unranked

44 citations

John E. Mullinax, Cheryl A. Cox, Amy M. Hall, Matthew Beatty, Jamie Blauvelt +18 more

Southwest Oncology Group S0826: A phase 2 trial of SCH 727965 (NSC 727135, dinaciclib) in patients with stage IV melanoma

Cancer(2024)10.1002/cncr.35587

N/A

0.539DataRank · unranked

9 citations

James Moon, T. Vincent, John P. Fruehauf, Lawrence E. Flaherty, Martin J. Bury +8 more

Immune adverse events (irAEs) with adjuvant ipilimumab in melanoma, use of immunosuppressants and association with outcome: ECOG-ACRIN E1609 study analysis

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002535

N/A

0.520DataRank · unranked

31 citations

Ni Kang, Sandra J. Lee, F. Stephen Hodi, Gary I. Cohen, Omid Hamid +16 more

Neoadjuvant PD-1 blockade in patients with resectable desmoplastic melanoma (SWOG 1512).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.9502

N/A

0.464DataRank · unranked

21 citations

James Moon, Zeynep Eroglu, Siwen Hu‐Lieskovan, William E. Carson, David A. Wada +15 more

Association between Human Polyomaviruses and Keratinocyte Carcinomas: A Prospective Cohort Study

Cancer Epidemiology Biomarkers & Prevention(2021)10.1158/1055-9965.epi-21-0332

N/A

0.292DataRank · unranked

6 citations

Yayi Zhao, Jane L. Messina, Michael J. Schell, Neil A. Fenske, Basil S. Cherpelis +9 more

Natural History of Incident and Persistent Cutaneous Human Papillomavirus and Human Polyomavirus Infections

The Journal of Infectious Diseases(2022)10.1093/infdis/jiac004

Top 59%

0.261DataRank

Top 59%4 citations

Yayi Zhao, Neil A. Fenske, Basil S. Cherpelis, Jane L. Messina, Anna R. Giuliano +8 more

S1801: A randomized trial of adjuvant versus neoadjuvant pembrolizumab for melanoma.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.tps9585

N/A

0.208DataRank · unranked

3 citations

Megan Othus, James Moon, Michael T. Tetzlaff, Elizabeth I. Buchbinder, Vernon K. Sondak +9 more

Immune adverse events (irAEs) with adjuvant ipilimumab in melanoma, use of hormone replacement and immunosuppressants, and association with outcome: E1609 study analysis.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.5_suppl.60

N/A

0.104DataRank · unranked

1 citations

Sandra J. Lee, Ni Kang, F. Stephen Hodi, Uma N. M. Rao, Gary I. Cohen +5 more

Patient-reported outcomes among patients with resected high-risk melanoma (AJCC7 IIIB, IIIC, M1a, M1b) randomized to low- or high-dose adjuvant Ipilimumab (ipi) versus high-dose interferon alfa-2b (HDI): Health-related quality of life (HRQL) analysis of ECOG-ACRIN E1609.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e22078

N/A

0.104DataRank · unranked

1 citations

Yue Zheng, Sandra J. Lee, F. Stephen Hodi, UMA RAO, Gary I. Cohen +4 more

Granulomatous and sarcoid-like immune related adverse events (irAEs) in melanoma patients following CTLA4 blockade adjuvant therapy: An analysis of 1670 high-risk patients.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.9582

N/A

0.104DataRank · unranked

1 citations

Ibrahim Yassine, Sandra J. Lee, Megan Othus, James Moon, John M. Kirkwood +5 more

Granulomatous and Sarcoid-like Immune-Related Adverse Events following CTLA4 and PD1 Blockade Adjuvant Therapy of Melanoma: A Combined Analysis of ECOG-ACRIN E1609 and SWOG S1404 Phase III Trials and a Literature Review

Cancers(2023)10.3390/cancers15092561

N/A

0DataRank · unranked

13 citations

Arish Noor, Mahati Paravathaneni, Ibrahim Yassine, Sandra J. Lee, Megan Othus +7 more

Combined BRAF, MEK, and heat‐shock protein 90 inhibition in advanced BRAF V600‐mutant melanoma

Cancer(2023)10.1002/cncr.35029

N/A

0DataRank · unranked

11 citations

Y. Ann Chen, Inna Smalley, Jiannong Li, Joseph Markowitz, Andrew S. Brohl +6 more

Data from PTEN Loss Confers BRAF Inhibitor Resistance to Melanoma Cells through the Suppression of BIM Expression

(2023)10.1158/0008-5472.c.6502911.v1

N/A

0DataRank · unranked

0 citations

Yun Xiang, Vito W. Rebecca, Ethan V. Abel, Y. Ann Chen, A. Cecilia Munko +11 more

Data from Cutaneous Human Papillomaviruses and the Risk of Keratinocyte Carcinomas

(2023)10.1158/0008-5472.c.6513619.v1

N/A

0DataRank · unranked

0 citations

Rossybelle P. Amorrortu, Yayi Zhao, Jane L. Messina, Michael J. Schell, Neil A. Fenske +9 more

Data from Cutaneous Human Papillomaviruses and the Risk of Keratinocyte Carcinomas

(2023)10.1158/0008-5472.c.6513619

N/A

0DataRank · unranked

0 citations

Rossybelle P. Amorrortu, Yayi Zhao, Jane L. Messina, Michael J. Schell, Neil A. Fenske +9 more

Data from Single-Cell Characterization of the Immune Microenvironment of Melanoma Brain and Leptomeningeal Metastases

(2023)10.1158/1078-0432.c.6530586.v1

Top 100%

0DataRank

Top 100%0 citations

Zhihua Chen, Manali Phadke, Jiannong Li, Xiaoqing Yu, Clayton Wyatt +15 more

Supplementary Table 5 from Single-Cell Characterization of the Immune Microenvironment of Melanoma Brain and Leptomeningeal Metastases

(2023)10.1158/1078-0432.22480995

Top 100%

0DataRank

Top 100%0 citations

Zhihua Chen, Manali Phadke, Jiannong Li, Xiaoqing Yu, Clayton Wyatt +15 more

Data from Adjuvant Pembrolizumab versus IFNα2b or Ipilimumab in Resected High-Risk Melanoma

(2023)10.1158/2159-8290.c.6549583.v1

N/A

0DataRank · unranked

0 citations

Megan Othus, Sapna P. Patel, Ahmad A. Tarhini, Vernon K. Sondak, Michael V. Knopp +26 more

Preexisting Skin-Resident CD8 and γδ T-cell Circuits Mediate Immune Response in Merkel Cell Carcinoma and Predict Immunotherapy Efficacy

Cancer Discovery(2024)10.1158/2159-8290.cd-23-0798

N/A

0DataRank · unranked

25 citations

Yue Zhang, Oscar E. Ospina, Matt D. Nichols, Victoria A. Chu, Álvaro de Mingo Pulido +31 more

Evaluation and Surgical Management of Pediatric Cutaneous Melanoma and Atypical Spitz and Non-Spitz Melanocytic Tumors (Melanocytomas): A Report From Children's Oncology Group

Journal of Clinical Oncology(2024)10.1200/jco.24.01154

N/A

0DataRank · unranked

21 citations

Raymond L. Barnhill, David E. Elder, Susan M. Swetter, Víctor G. Prieto, Jennifer S. Ko +28 more

Neoadjuvant Intratumoral Plasmid IL-12 Electro-Gene-Transfer and Nivolumab in Patients with Operable, Locoregionally Advanced Melanoma

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-2768

N/A

0DataRank · unranked

11 citations

Zeynep Eroglu, Islam Eljilany, Jonathan S. Zager, R. Gonzalez, Amod A. Sarnaik +13 more

First-in-Human Stage III/IV Melanoma Clinical Trial of Immune Priming Agent IFx-Hu2.0

Molecular Cancer Therapeutics(2024)10.1158/1535-7163.mct-23-0652

N/A

0DataRank · unranked

9 citations

Michael J. Shamblott, Andrew S. Brohl, Amod A. Sarnaik, Zeynep Eroglu, Nikhil I. Khushalani +13 more

Differential histone acetylation and super-enhancer regulation underlie melanoma cell dedifferentiation

JCI Insight(2024)10.1172/jci.insight.166611

N/A

0DataRank · unranked

5 citations

Tiphaine Martin, Christie B. Nguyen, Min Hsu, Jia Xu, Claudia Lang +10 more

The Association of MUC16 Mutation with Tumor Mutation Burden and Its Prognostic Implications in Cutaneous Melanoma

Cancer Epidemiology Biomarkers & Prevention(2020)10.1158/1055-9965.epi-20-0307

N/A

0DataRank · unranked

19 citations

Xiaoqing Yu, Michael Krauthammer, Willy Hugo, Chunzhe Duan, Peter A. Kanetsky +9 more

1695eP Systematic evaluation of polygenic risk scores (PRS) for autoimmune thyroid disease and the risk of thyroiditis following checkpoint immunotherapy (ICI) of melanoma in a North American patient (pt) population

Annals of Oncology(2025)10.1016/j.annonc.2025.08.2322

N/A

0DataRank · unranked

0 citations

Zhihua Chen, Seok-Joo Lee, F.S. Hodi, Yuying Li, Howard Streicher +5 more

Cutaneous viral infections associated with ultraviolet radiation exposure

International Journal of Cancer(2020)10.1002/ijc.33263

N/A

0DataRank · unranked

10 citations

Rossybelle P. Amorrortu, Neil A. Fenske, Basil S. Cherpelis, Jane L. Messina, Vernon K. Sondak +9 more

S1801: A randomized phase II trial of adjuvant versus neoadjuvant pembrolizumab (PEM) for melanoma.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps10090

N/A

0DataRank · unranked

1 citations

Megan Othus, James Moon, Michael T. Tetzlaff, Elizabeth I. Buchbinder, Vernon K. Sondak +8 more

Unknown primary tumor high-risk melanoma as a unique patient population with distinct prognosis in the adjuvant setting: An ECOG-ACRIN E1609 study analysis.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e22090

N/A

0DataRank · unranked

0 citations

Sandra J. Lee, F. Stephen Hodi, Gary I. Cohen, UMA RAO, Vernon K. Sondak +2 more

Single-Cell Characterization of the Immune Microenvironment of Melanoma Brain and Leptomeningeal Metastases

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-1694

N/A

0DataRank · unranked

166 citations

Zhihua Chen, Manali Phadke, Jiannong Li, Xiaoqing Yu, Clayton Wyatt +15 more

Adjuvant Pembrolizumab versus IFNα2b or Ipilimumab in Resected High-Risk Melanoma

Cancer Discovery(2021)10.1158/2159-8290.cd-21-1141

N/A

0DataRank · unranked

102 citations

Megan Othus, Sapna P. Patel, Ahmad A. Tarhini, Vernon K. Sondak, Michael V. Knopp +26 more

Cutaneous Human Papillomaviruses and the Risk of Keratinocyte Carcinomas

Cancer Research(2021)10.1158/0008-5472.can-21-0805

N/A

0DataRank · unranked

24 citations

Rossybelle P. Amorrortu, Yayi Zhao, Jane L. Messina, Michael J. Schell, Neil A. Fenske +9 more

88 Evidence of enhanced immune activation within the tumor microenvironment and the circulation of female patients with high-risk melanoma compared to males

Regular and Young Investigator Award Abstracts(2021)10.1136/jitc-2021-sitc2021.088

N/A

0DataRank · unranked

1 citations

Aik Choon Tan, Issam El Naqa, Sandra Lee, F. Stephen Hodi, Lisa H. Butterfield +9 more

1073P Quality of life (QOL) endpoints from the phase III intergroup S1404 adjuvant melanoma trial

Annals of Oncology(2021)10.1016/j.annonc.2021.08.1458

N/A

0DataRank · unranked

0 citations

Joseph M. Unger, Megan Othus, Amy K. Darke, Ahmad A. Tarhini, John M. Kirkwood +5 more

87 Enhanced immunogenicity within the tumor microenvironment and the circulation of high-risk melanoma patients with unknown primary compared to those whose primary melanoma is known

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-sitc2021.087

N/A

0DataRank · unranked

0 citations

Aik Choon Tan, Issam El Naqa, Sandra Lee, F. Stephen Hodi, Lisa H. Butterfield +8 more

Improved prognosis and evidence of enhanced immunogenicity in tumor and circulation of high-risk melanoma patients with unknown primary

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2021-004310

N/A

0DataRank · unranked

19 citations

Sandra J. Lee, Aik Choon Tan, Issam M. El Naqa, F. Stephen Hodi, Lisa H. Butterfield +9 more

Patterns of recurrence and prognosis in pathologic stage I and II Merkel cell carcinoma: A multicenter, retrospective cohort analysis

Journal of the American Academy of Dermatology(2022)10.1016/j.jaad.2022.05.019

N/A

0DataRank · unranked

1 citations

Adrienne B. Shannon, Michael J. Carr, James Sun, Karenia Landa, Kirsten Baecher +14 more

IFx-Hu2.0 phase I first in human study for unresectable melanoma for an intralesional “in-situ vaccine” approach.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e21542

N/A

0DataRank · unranked

6 citations

Michael J. Shamblott, Andrew S. Brohl, Amod A. Sarnaik, Zeynep Eroglu, Nikhil I. Khushalani +7 more

Survival trends among patients diagnosed with both melanoma and chronic lymphocytic leukemia.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e19527

N/A

0DataRank · unranked

0 citations

Rossybelle P. Amorrortu, Sandra C. Stewart, Kavita Ghia, Vonetta L. Williams, Vernon K. Sondak +5 more

Vernon K. Sondak

Indexed papers

Top data-sharing exemplar

Papers